Epidemics caused by dangerous pathogens such as Ebola virus can occur without warning. The administration of protective antibodies against a pathogen is one approach to save lives and reduce the number of victims. How can they be produced quickly and in large quantities in the event of outbreaks? Researchers at the Paul-EhrlichInstitut with scientists at DZIF (German Center for Infection Research) have shown that adjuvanted virus-like particles (VLPs) could be used as a plug-and-play system to rapidly generate functional antibodies in animals that could then be used to treat infected individuals. The results are reported in the online edition of npj Vaccines on 05.10.2018.
Outbreaks of infectious diseases can sometimes reach epidemic proportions, such as the large Ebola virus outbreak in Western Africa in 2014, which resulted in more than 28,500 infections and 11,000 deaths.
A new Ebola outbreak in the Democratic Republic of the Congo is currently being fought. Nipah and Hendra viruses are examples of other dangerous pathogens, which have thus far caused only minor outbreaks, such as the Nipah outbreak ongoing in India.
Effective vaccines against known pathogens have been available for many years. However, in the event of an outbreak with new life-threatening pathogens, therapeutics are needed that can be produced very quickly for many people and provide protection until a vaccine becomes available. Passive immunisation, the administration of convalescent plasma containing specific functional antibodies, provides a straight forward way to treat infected individuals.
Here one makes use of the fact that during an infection, antibodies are produced by the immune system and then circulate in the blood of the convalescent patient. The convalescents' blood plasma, which contains sufficient levels of neutralising antibodies against the specific pathogen, can then be administered to newly infected patients and protect them from disease, or at least prevent severe outcomes.
However, convalescent plasma is often scarce, since only individuals who have already recovered from the disease can serve as donors. Here the production of hyperimmune sera in animals constitutes an attractive alternative. Researchers at Paul Ehrlich Institute led by Prof. Veronika von Messling, Director of the Division of Veterinary Medicine, have collaborated with researchers from the Universities of Marburg and Munich as part of the German Center for Infection Research (DZIF) using Ebola and Nipah viruses as models to investigate how the production of functional antibodies in rabbits can be induced as effectively as possible.
The researchers found that adjuvanted virus-like particles (VLPs) efficiently stimulated the production of functional antibodies at high titers in animals. VLP-based vaccines are particularly interesting because the immune system recognises them as virus particles, but VLPs do not multiply in target cells.
The high antibody titres observed here indicate that de novo antigen expression is less important for the production of functional antibodies than the presentation of the antigen in its natural form. With an optimised purification process, concentrated polyclonal antibodies were obtained that were stable in vivo.
Such polyclonal antibody concentrates have the advantage to be directed against different sites (epitopes) of the pathogen, so there is less risk of loss of function due to mutations in the virus compared to monoclonal antibodies which are directed against only one epitope.
Nipah VLPs were also able to induce the production of high-titre functional antibodies. VLPs can be produced in sufficient quantities for the immunisation of animals within one to two weeks, and can be produced for different pathogens, so that they could potentially be used as a convenient plug-and-play system for antibody production.
"We consider the production of polyclonal antibodies using pathogen-adapted adjuvanted VLPs a promising approach for the rapid delivery of protective immune sera in the event of outbreaks of new dangerous viruses", says Dr. Veronika von Messling in explaining the research team’s results.
Phone: +49 6103 77 1030
SchmidtR, Beltzig LC, Sawatsky B, Dolnik O, Dietzel E,
Krähling V, Volz A, Sutter G, Becker S, von Messling V (2018): Generation of therapeutic antisera for emerging viral infections. NPJ Vaccines. 2018 Okt
NPJ Vaccines 3, Article number: 42 (2018) https://doi.org/10.1038/s41541-018-0082-4
Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft
Machine learning microscope adapts lighting to improve diagnosis
20.11.2019 | Duke University
The neocortex is critical for learning and memory
20.11.2019 | Max-Planck-Institut für Hirnforschung
Conventional light microscopes cannot distinguish structures when they are separated by a distance smaller than, roughly, the wavelength of light. Superresolution microscopy, developed since the 1980s, lifts this limitation, using fluorescent moieties. Scientists at the Max Planck Institute for Polymer Research have now discovered that graphene nano-molecules can be used to improve this microscopy technique. These graphene nano-molecules offer a number of substantial advantages over the materials previously used, making superresolution microscopy even more versatile.
Microscopy is an important investigation method, in physics, biology, medicine, and many other sciences. However, it has one disadvantage: its resolution is...
Nanooptical traps are a promising building block for quantum technologies. Austrian and German scientists have now removed an important obstacle to their practical use. They were able to show that a special form of mechanical vibration heats trapped particles in a very short time and knocks them out of the trap.
By controlling individual atoms, quantum properties can be investigated and made usable for technological applications. For about ten years, physicists have...
An international team of scientists, including three researchers from New Jersey Institute of Technology (NJIT), has shed new light on one of the central mysteries of solar physics: how energy from the Sun is transferred to the star's upper atmosphere, heating it to 1 million degrees Fahrenheit and higher in some regions, temperatures that are vastly hotter than the Sun's surface.
With new images from NJIT's Big Bear Solar Observatory (BBSO), the researchers have revealed in groundbreaking, granular detail what appears to be a likely...
The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM in Dresden has succeeded in using Selective Electron Beam Melting (SEBM) to...
Carbon nanotubes (CNTs) are valuable for a wide variety of applications. Made of graphene sheets rolled into tubes 10,000 times smaller than a human hair, CNTs have an exceptional strength-to-mass ratio and excellent thermal and electrical properties. These features make them ideal for a range of applications, including supercapacitors, interconnects, adhesives, particle trapping and structural color.
New research reveals even more potential for CNTs: as a coating, they can both repel and hold water in place, a useful property for applications like printing,...
15.11.2019 | Event News
15.11.2019 | Event News
05.11.2019 | Event News
20.11.2019 | Life Sciences
20.11.2019 | Physics and Astronomy
20.11.2019 | Health and Medicine